Cargando…
Efficacy of the Therapeutic Game “Trisquel” in the Treatment of Patients With Substance-Related Disorders Randomized Clinical Study
Substance-related disorders (SRD) have been consistently associated with alterations both in cognitive and executive functions, which affect to patients’ quality of life. The main objective of this work was to test the beneficial cognitive effects on patients with SRD after the implementation of “Tr...
Autores principales: | Piñón-Blanco, Adolfo, Vergara-Moragues, Esperanza, Gutiérrez-Martínez, Olga, Fernández-Palleiro, Patricia, Rodrigues, Sonia, Rodrigues-Amorím, Daniela, Lage-López, María Teresa, González-López, Ana, Velasquez, Teresa, Amorim, Mónica, Lloves-Moratinos, Manuel, Viéitez-Fernández, Isabel, Sabio-Fernandez, Gerardo, Graña-Torralba, Rebeca, Vilar-Díaz, Vanesa, Carrera-Machado, Indalecio, Cancelo-Martinez, Jesús, Ferreira, Adelino, Cardoso, Susana, Rivera-Baltanás, Tania, Otero-Lamas, Francisco, Olivares, José Manuel, Spuch, Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108152/ https://www.ncbi.nlm.nih.gov/pubmed/35586410 http://dx.doi.org/10.3389/fpsyt.2022.864511 |
Ejemplares similares
-
A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine
por: Rodrigues-Amorim, Daniela, et al.
Publicado: (2020) -
Does Lithium Deserve a Place in the Treatment Against COVID-19? A Preliminary Observational Study in Six Patients, Case Report
por: Spuch, Carlos, et al.
Publicado: (2020) -
The Role of the Second Extracellular Loop of Norepinephrine Transporter, Neurotrophin-3 and Tropomyosin Receptor Kinase C in T Cells: A Peripheral Biomarker in the Etiology of Schizophrenia
por: Rodrigues-Amorim, Daniela, et al.
Publicado: (2021) -
Plasma β-III tubulin, neurofilament light chain and glial fibrillary acidic protein are associated with neurodegeneration and progression in schizophrenia
por: Rodrigues-Amorim, Daniela, et al.
Publicado: (2020) -
Proteomics in Schizophrenia: A Gateway to Discover Potential Biomarkers of Psychoneuroimmune Pathways
por: Rodrigues-Amorim, Daniela, et al.
Publicado: (2019)